A detailed history of Spartan Planning & Wealth Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Spartan Planning & Wealth Management holds 268 shares of EW stock, worth $19,864. This represents 0.02% of its overall portfolio holdings.

Number of Shares
268
Holding current value
$19,864
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 12, 2024

BUY
$61.71 - $77.76 $16,538 - $20,839
268 New
268 $20,000
Q2 2022

Aug 10, 2022

SELL
$86.5 - $128.27 $180,093 - $267,058
-2,082 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $212,280 - $267,203
2,082 New
2,082 $245,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Spartan Planning & Wealth Management Portfolio

Follow Spartan Planning & Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spartan Planning & Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spartan Planning & Wealth Management with notifications on news.